Osborn D A, Sinn J
Cochrane Database Syst Rev. 2004(3):CD003741. doi: 10.1002/14651858.CD003741.pub2.
Allergies and food reactions in infants and children are common and may be associated with foods including adapted cow's milk formulas. Soy based formulas have been used to treat infants with allergy or food intolerance. However, it is unclear whether they can be advocated for the prevention of allergy and food intolerance in infants without clinical evidence of allergy or food intolerance.
In infants without clinical evidence of allergy or food intolerance, to determine whether feeding them an adapted soy formula compared to human milk, cow's milk formula or a hydrolysed protein formula prevents allergy or food intolerance.
The standard search strategy of the Cochrane Neonatal Review Group was used including searches of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 4, 2003), MEDLINE (1966 - January 2004), EMBASE (1980 - January 2004), CINAHL (1982 - December 2003) and previous reviews including cross references.
Randomised and quasi-randomised trials that compare the use of an adapted soy formula to human milk, an adapted cow's milk or a hydrolysed protein formula for infant feeding in the first 6 months. Only trials with > 80% follow up of participants and reported in group of assignment were eligible for inclusion.
Eligibility of studies for inclusion, methodological quality and data extraction were assessed independently by each reviewer. Primary outcomes included clinical allergy, specific allergies and food intolerance. Meta-analysis was conducted using a fixed effects model where no heterogeneity of treatment effect existed, and a random effects model when heterogeneity was found.
Five eligible studies were found, all enrolling infants at high risk of allergy on the basis of a family history of allergy in a first degree relative. All studies compared use of a soy to a cow's milk formula. Two studies also included a group fed a formula containing hydrolysed protein. No eligible study enrolled infants fed human milk. No study examined the effect of early, short term soy formula feeding. Three studies were of good methodology and did not have unbalanced allergy-preventing co-interventions in the treatment groups. Comparing soy to cow's milk formula, one study with unclear allocation concealment and 19.5% losses to follow up reported a reduction in cumulative incidence of childhood allergy, asthma and allergic rhinitis. No other study reported a significant benefit for any allergy or food intolerance. Analysis found no significant difference in allergy cumulative incidence in infancy (one study: RR 1.02, 95% CI 0.69, 1.49) or childhood (3 studies: typical RR 0.73, 95% CI 0.37, 1.44) and no significant difference in cumulative incidence or period prevalence of any specific allergy or food intolerance in infancy or childhood. Analysis of studies comparing soy to a hydrolysed formula found a significant increase in infant (one study: RR 1.67, 95% CI 1.03, 2.69) and childhood allergy cumulative incidence (one study: RR 1.55, 95% CI 1.02, 2.35), infant eczema cumulative incidence (2 studies: typical RR 2.34, 95% CI 1.51, 3.62) and childhood food allergy period prevalence (one study: RR 1.81, 95% CI 1.09, 3.02).
REVIEWERS' CONCLUSIONS: Feeding with a soy formula should not be recommended for the prevention of allergy or food intolerance in infants at high risk of allergy or food intolerance.
婴儿和儿童的过敏及食物反应很常见,可能与包括适配牛奶配方奶在内的食物有关。大豆配方奶已被用于治疗过敏或食物不耐受的婴儿。然而,在没有过敏或食物不耐受临床证据的情况下,大豆配方奶是否能用于预防婴儿的过敏和食物不耐受尚不清楚。
对于没有过敏或食物不耐受临床证据的婴儿,确定与母乳、牛奶配方奶或水解蛋白配方奶相比,喂养他们适配大豆配方奶是否能预防过敏或食物不耐受。
采用Cochrane新生儿综述小组的标准检索策略,包括检索Cochrane对照试验中心注册库(CENTRAL,Cochrane图书馆,2003年第4期)、MEDLINE(1966年 - 2004年1月)、EMBASE(1980年 - 2004年1月)、CINAHL(1982年 - 2003年12月)以及以往的综述,包括交叉参考文献。
随机和半随机试验,比较在婴儿出生后头6个月内,使用适配大豆配方奶与母乳、适配牛奶配方奶或水解蛋白配方奶进行喂养的情况。只有随访率>80%且按分配组报告的试验才有资格纳入。
每位综述员独立评估纳入研究的合格性、方法学质量和数据提取情况。主要结局包括临床过敏、特异性过敏和食物不耐受。当治疗效果不存在异质性时,采用固定效应模型进行荟萃分析;当发现异质性时,则采用随机效应模型。
共找到5项合格研究,所有研究纳入的婴儿均因一级亲属有过敏家族史而具有过敏高风险。所有研究均比较了大豆配方奶与牛奶配方奶的使用情况。两项研究还纳入了一组喂养含水解蛋白配方奶的婴儿。没有合格研究纳入母乳喂养的婴儿。没有研究考察早期、短期大豆配方奶喂养的效果。三项研究方法良好,治疗组中没有不平衡的预防过敏协同干预措施。将大豆配方奶与牛奶配方奶进行比较,一项分配隐藏情况不明且随访失访率为19.5%的研究报告称,儿童过敏、哮喘和过敏性鼻炎的累积发病率有所降低。没有其他研究报告对任何过敏或食物不耐受有显著益处。分析发现,婴儿期(一项研究:RR 1.02,95%CI 0.69,1.49)或儿童期(三项研究:典型RR 0.73,95%CI 0.37,1.44)过敏累积发病率无显著差异,婴儿期或儿童期任何特异性过敏或食物不耐受的累积发病率或期间患病率也无显著差异。对比较大豆配方奶与水解配方奶的研究进行分析发现,婴儿期(一项研究:RR 1.67,95%CI 1.03,2.69)和儿童期过敏累积发病率(一项研究:RR 1.55,95%CI 1.02,2.35)、婴儿期湿疹累积发病率(两项研究:典型RR 2.34,95%CI 1.51,3.62)以及儿童期食物过敏期间患病率(一项研究:RR 1.81,95%CI 1.09,3.02)均显著增加。
对于有过敏或食物不耐受高风险的婴儿,不建议使用大豆配方奶来预防过敏或食物不耐受。